Literature DB >> 13885617

Adjunctive use of a biologic pressor agent, angiotensin, in management of shock.

J R DERRICK, J R ANDERSON, B J ROLAND.   

Abstract

Keywords:  HYPERTENSIN/pharmacology; SHOCK/experimental

Mesh：

Substances：

Year:  1962        PMID： 13885617     DOI： 10.1161/01.cir.25.1.263

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  STUDIES ON THE RELATIVE CARDIAC AND PERIPHERAL ACTIONS OF ANGIOTENSIN.

Authors:  W B BERRY; W G AUSTEN; W D CLARK
Journal:  Ann Surg       Date:  1964-04       Impact factor: 12.969

2.  Vasopressor hormones in shock-noradrenaline, vasopressin or angiotensin II: which one will make the race?

Authors:  Martin W Dünser; Jens Meier
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

3.  Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review.

Authors:  Mathieu Jozwiak; Guillaume Geri; Driss Laghlam; Kevin Boussion; Charles Dolladille; Lee S Nguyen
Journal:  Front Med (Lausanne)       Date:  2022-05-23

4.  The use of angiotensin II in distributive shock.

Authors:  Lakhmir S Chawla; Laurence W Busse; Ermira Brasha-Mitchell; Ziyad Alotaibi
Journal:  Crit Care       Date:  2016-05-27       Impact factor: 9.097

Review 5.  The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.

Authors:  Olga Papazisi; Meindert Palmen; A H Jan Danser
Journal:  Cardiovasc Drugs Ther       Date:  2020-10-21       Impact factor: 3.947
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.